- Home
- CNTA vs POR Comparison
CNTA vs POR Comparison
Compare CNTA & POR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTA | POR |
|---|---|---|
| Founded | 2020 | 1889 |
| Country | United Kingdom | United States |
| Employees | N/A | 2915 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.8B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CNTA | POR |
|---|---|---|
| Price | $39.68 | $50.48 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 11 |
| Target Price | $43.17 | ★ $48.55 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 05-13-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.32% |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | $15,000,000.00 | ★ $3,576,000,000.00 |
| Revenue This Year | N/A | $6.94 |
| Revenue Next Year | N/A | $5.83 |
| P/E Ratio | ★ N/A | $130.71 |
| Revenue Growth | N/A | ★ 3.95 |
| 52 Week Low | $11.55 | $39.55 |
| 52 Week High | $40.26 | $54.62 |
Technical Indicators
Market Signals| Indicator | CNTA | POR |
|---|---|---|
| Relative Strength Index (RSI) | 62.46 | 54.74 |
| Support Level | $39.36 | $50.29 |
| Resistance Level | $39.86 | $51.43 |
| Average True Range (ATR) | 0.13 | 0.99 |
| MACD | -0.15 | 0.18 |
| Stochastic Oscillator | 25.93 | 77.17 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About POR Portland General Electric Co
Portland General Electric is a regulated electric utility providing generation, transmission, and distribution services in a service territory that includes about half of all Oregon residents and two-thirds of the state's business activity. The company owns (wholly or through joint ventures) 3.6 gigawatts of gas, coal, wind, and hydro generation, along with 300 megawatts of energy storage. In February 2026, PGE proposed acquiring utilities in Washington state from Berkshire Hathaway Energy.